ZA200704394B - Compositions for combating beta-lactamase-mediated antiboitic resistance using beta-lactamase inhibitors useful for injection - Google Patents
Compositions for combating beta-lactamase-mediated antiboitic resistance using beta-lactamase inhibitors useful for injectionInfo
- Publication number
- ZA200704394B ZA200704394B ZA200704394A ZA200704394A ZA200704394B ZA 200704394 B ZA200704394 B ZA 200704394B ZA 200704394 A ZA200704394 A ZA 200704394A ZA 200704394 A ZA200704394 A ZA 200704394A ZA 200704394 B ZA200704394 B ZA 200704394B
- Authority
- ZA
- South Africa
- Prior art keywords
- beta
- lactamase
- compositions
- normally
- sodium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2411DE2004 | 2004-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200704394B true ZA200704394B (en) | 2008-09-25 |
Family
ID=35789266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200704394A ZA200704394B (en) | 2004-12-02 | 2007-05-29 | Compositions for combating beta-lactamase-mediated antiboitic resistance using beta-lactamase inhibitors useful for injection |
Country Status (23)
Country | Link |
---|---|
US (2) | US8273732B2 (ru) |
EP (1) | EP1841432B1 (ru) |
JP (1) | JP5269415B2 (ru) |
KR (2) | KR101244362B1 (ru) |
CN (1) | CN101060846A (ru) |
AT (1) | ATE476981T1 (ru) |
AU (1) | AU2005310888B2 (ru) |
BR (1) | BRPI0517128A (ru) |
CY (1) | CY1110886T1 (ru) |
DE (1) | DE602005022939D1 (ru) |
DK (1) | DK1841432T3 (ru) |
ES (1) | ES2349301T3 (ru) |
HR (1) | HRP20100591T1 (ru) |
MX (1) | MX2007006540A (ru) |
NZ (1) | NZ555075A (ru) |
PL (1) | PL1841432T3 (ru) |
PT (1) | PT1841432E (ru) |
RS (1) | RS51506B (ru) |
RU (1) | RU2397768C2 (ru) |
SI (1) | SI1841432T1 (ru) |
UA (1) | UA91204C2 (ru) |
WO (1) | WO2006059344A1 (ru) |
ZA (1) | ZA200704394B (ru) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030010176A (ko) * | 2001-07-25 | 2003-02-05 | 이병두 | 은행 열매 추출물과 호도 열매 추출물을 이용한 천식 치료제 |
CN101129382B (zh) * | 2006-08-25 | 2013-12-25 | 天津和美生物技术有限公司 | 含β-内酰胺类抗生素和缓冲组分的抗生素复方 |
CN101129381B (zh) * | 2006-08-25 | 2012-02-01 | 天津和美生物技术有限公司 | 含β-内酰胺类抗生素和离子螯合剂的抗生素复方 |
WO2010013640A1 (ja) * | 2008-07-28 | 2010-02-04 | Yamaguchi Keizo | 感染症治療効果増強剤 |
CN101537009B (zh) * | 2009-04-30 | 2010-09-15 | 海口奇力制药股份有限公司 | 注射用头孢曲松钠他唑巴坦钠复方制剂的生产工艺 |
JP2012176899A (ja) * | 2009-05-19 | 2012-09-13 | Mitsubishi Tanabe Pharma Corp | 2−(1−ピペラジニル)−5−メチルベンゼンスルホン酸誘導体を含む注射用水溶液 |
KR20140035376A (ko) * | 2011-05-28 | 2014-03-21 | 욱크하르트 리미티드 | 항균제 및 타조박탐을 포함하는 조성물 |
US9095594B2 (en) * | 2011-07-26 | 2015-08-04 | Wockhardt Ltd. | Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor |
WO2013042140A2 (en) * | 2011-09-23 | 2013-03-28 | Manu Chaudhary | Non antibiotic,non peptide compounds for antibiotic efficacy & safety enhancement |
GEP20166470B (en) | 2012-03-26 | 2016-04-25 | Santen Pharmaceutical Co Ltd | Diquafosol-containing eye drop |
NZ702415A (en) | 2012-06-07 | 2016-04-29 | Children’S Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
CA2886402A1 (en) * | 2012-09-27 | 2014-04-03 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine antibiotic compositions |
RU2016136833A (ru) | 2014-02-18 | 2018-03-22 | Чилдрен'З Хоспитал Лос Анджелес | Композиции и способы для лечения нейтропении |
US20170151221A1 (en) * | 2014-03-29 | 2017-06-01 | Wockhardt Limited | Pharmaceutical compositions comprising cefepime or sulbactam |
CA2914314C (en) * | 2014-04-03 | 2021-05-18 | Baxter International Incorporated | Injection bag and injection preparation assembly |
US10201518B2 (en) | 2016-09-28 | 2019-02-12 | The University Of Hong Kong | Bismuth(III) compounds and methods thereof |
US10668079B2 (en) | 2016-11-02 | 2020-06-02 | Xiangbei Welman Pharmaceutical Co., Ltd. | Composition composed of ceftriaxone sodium and sulbactum sodium |
CN106822147B (zh) * | 2016-11-03 | 2021-07-20 | 湘北威尔曼制药股份有限公司 | 一种头孢曲松钠和舒巴坦钠组合物、包含该组合物的药物制剂及其应用 |
RU2665006C1 (ru) * | 2017-02-28 | 2018-08-24 | Общество с ограниченной ответственностью "Супербаг Солюшенс" | Композиция антимикробных препаратов для лечения инфекционных заболеваний людей и животных и способ её применения |
US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6630510B1 (en) * | 1999-10-28 | 2003-10-07 | Merck & Co., Inc. | Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections |
US6677320B2 (en) * | 2000-01-20 | 2004-01-13 | Hoffmann-La Roches Inc. | Parenteral bisphosphonate composition with improved local tolerance |
PT1468697E (pt) * | 2003-04-14 | 2008-03-05 | Wyeth Corp | Composições contendo piperacilina e tazobactam úteis para injecção |
-
2005
- 2005-11-28 AU AU2005310888A patent/AU2005310888B2/en not_active Ceased
- 2005-11-28 CN CNA2005800395645A patent/CN101060846A/zh active Pending
- 2005-11-28 PT PT05817957T patent/PT1841432E/pt unknown
- 2005-11-28 KR KR1020097018388A patent/KR101244362B1/ko active IP Right Grant
- 2005-11-28 ES ES05817957T patent/ES2349301T3/es active Active
- 2005-11-28 EP EP05817957A patent/EP1841432B1/en active Active
- 2005-11-28 KR KR1020077010375A patent/KR20070067189A/ko not_active Application Discontinuation
- 2005-11-28 SI SI200531130T patent/SI1841432T1/sl unknown
- 2005-11-28 BR BRPI0517128-8A patent/BRPI0517128A/pt not_active IP Right Cessation
- 2005-11-28 MX MX2007006540A patent/MX2007006540A/es active IP Right Grant
- 2005-11-28 US US11/720,710 patent/US8273732B2/en not_active Expired - Fee Related
- 2005-11-28 DE DE602005022939T patent/DE602005022939D1/de active Active
- 2005-11-28 DK DK05817957.3T patent/DK1841432T3/da active
- 2005-11-28 UA UAA200707280A patent/UA91204C2/ru unknown
- 2005-11-28 RU RU2007124325/15A patent/RU2397768C2/ru not_active IP Right Cessation
- 2005-11-28 PL PL05817957T patent/PL1841432T3/pl unknown
- 2005-11-28 JP JP2007544016A patent/JP5269415B2/ja not_active Expired - Fee Related
- 2005-11-28 NZ NZ555075A patent/NZ555075A/en not_active IP Right Cessation
- 2005-11-28 WO PCT/IN2005/000382 patent/WO2006059344A1/en active Application Filing
- 2005-11-28 RS RSP-2010/0465A patent/RS51506B/en unknown
- 2005-11-28 AT AT05817957T patent/ATE476981T1/de active
-
2007
- 2007-05-29 ZA ZA200704394A patent/ZA200704394B/xx unknown
-
2010
- 2010-11-03 HR HR20100591T patent/HRP20100591T1/hr unknown
- 2010-11-10 CY CY20101101012T patent/CY1110886T1/el unknown
-
2012
- 2012-09-25 US US13/626,236 patent/US9012442B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2005310888A1 (en) | 2006-06-08 |
JP5269415B2 (ja) | 2013-08-21 |
WO2006059344B1 (en) | 2006-11-02 |
EP1841432A1 (en) | 2007-10-10 |
WO2006059344A1 (en) | 2006-06-08 |
CY1110886T1 (el) | 2015-06-10 |
US20100160277A1 (en) | 2010-06-24 |
DK1841432T3 (da) | 2010-12-06 |
KR20070067189A (ko) | 2007-06-27 |
PL1841432T3 (pl) | 2011-01-31 |
UA91204C2 (ru) | 2010-07-12 |
ES2349301T3 (es) | 2010-12-29 |
KR20090101514A (ko) | 2009-09-28 |
EP1841432B1 (en) | 2010-08-11 |
SI1841432T1 (sl) | 2011-02-28 |
HRP20100591T1 (hr) | 2010-12-31 |
RU2007124325A (ru) | 2009-01-10 |
CN101060846A (zh) | 2007-10-24 |
JP2008521884A (ja) | 2008-06-26 |
PT1841432E (pt) | 2010-10-25 |
DE602005022939D1 (de) | 2010-09-23 |
US8273732B2 (en) | 2012-09-25 |
ATE476981T1 (de) | 2010-08-15 |
KR101244362B1 (ko) | 2013-03-18 |
AU2005310888B2 (en) | 2011-01-06 |
US9012442B2 (en) | 2015-04-21 |
RU2397768C2 (ru) | 2010-08-27 |
MX2007006540A (es) | 2008-01-31 |
US20130023512A1 (en) | 2013-01-24 |
RS51506B (en) | 2011-06-30 |
NZ555075A (en) | 2011-02-25 |
BRPI0517128A (pt) | 2008-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200704394B (en) | Compositions for combating beta-lactamase-mediated antiboitic resistance using beta-lactamase inhibitors useful for injection | |
JP7245289B2 (ja) | 細菌感染症の処置方法 | |
Martirosov et al. | Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae | |
CO5700796A2 (es) | Composiciones que contienen piperacilina y tazobactam utiles para inyecciones | |
US20060189584A1 (en) | Pharmaceutical combinations | |
JP2015147783A (ja) | メチルナルトレキソンを含む医薬処方物 | |
WO2007112000A3 (en) | Treatment of pain | |
WO2009017838A3 (en) | Combinations of jak-2 inhibitors and other agents | |
TW200639159A (en) | Treatment of pain | |
CA2597812A1 (en) | Parenteral combination therapy for infective conditions with drug resistant bacterium | |
JP2008540515A (ja) | 嚢胞性線維症を含む重症感染症の処置および管理 | |
MX2023013890A (es) | Compuesto heterociclico que contiene nitrogeno, metodo de preparacion del mismo y aplicacion del mismo en medicamentos. | |
AU2009246603A8 (en) | Von willebrand factor (vwf) inhibitors for treatment or prevention of infarction | |
CA2633077A1 (en) | Solid-state form of amg 706 and pharmaceutical compositions thereof | |
JP2023012538A (ja) | 細菌感染症を処置する方法 | |
WO2005092442B1 (en) | Method and compositions for treatment of chronic neuropathic pain | |
Scheinfeld | Extensive hidradenitis suppurativa (HS) Hurly stage III disease treated with intravenous (IV) linezolid and meropenem with rapid remission | |
CN1709263A (zh) | 抗菌素组合物 | |
WO2022177968A8 (en) | Therapeutic methods | |
Teng et al. | Piperacillin–Tazobactam | |
EP2979694A1 (en) | Succinic acid compounds for use in bacterial infections | |
JP2017508769A5 (ru) | ||
CO et al. | Pascalis Vergidis and Matthew E. Falagas | |
Vergidis et al. | Beta-Lactamase Inhibitors | |
TW200618812A (en) | Compositions containing piperacillin and tazobactam useful for injection |